CTRI/2021/08/035395已完成未知
Evaluation of Skin Safety of 3 topical formulations (Minoxidil 5% and Finasteride 0.1%) for Primary Skin Irritation Using Skin Irritation Test Patch Test in Humans (IS 4011:2018 Guidelines).
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 53
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Fitzpatrick skin type III to IV.
- •Having apparently healthy skin on test area
- •Willingness to avoid intense UV exposure on test site (sun or artificial UV), during the course of the trial.
排除标准
- •Pregnancy (by history) and lactating women.
- •Scars, excessive terminal hair or tattoo on the studied area
- •Hypersensitivity, allergy antecedent (to any cosmetic product, raw
- •material, hair dye)
研究者
相似试验
已完成
不适用
To test the safety of 3 test products for skin irritatioCTRI/2020/08/027431Sun Pharmaceutical Industries Ltd56
已完成
不适用
To test the safety of 3 test products for skin irritatioCTRI/2021/03/032023Sun Pharmaceutical Industries Ltd56
已完成
不适用
To determine safety of 3 products on human skin, post removal of product filled patch after 24 hours of application.CTRI/2021/07/034825Mr Amol Khedkar
尚未招募
不适用
To Assess the dermatological safety of 3 investigational products, by a 24-hour patch test on healthy volunteersCTRI/2021/07/035026Skinovate Laser Cosmetic Surgery Centre
已完成
不适用
To check the safety of 3 test product for skin irritationCTRI/2021/04/033206yka Labs Limited56